The wealth of information contained in our genetic code has led to leaps in the diagnosis and treatment of disease. But in addition to regulated medical uses, commercial applications have sparked public curiosity for everything from learning about your genetic predispositions to identifying your ancestral roots, to dating and dieting advice.
In this meeting of The Berkeley Ethics and Regulation Group for Innovative Technologies (BERGIT), we will build on the last meeting’s themes, and examine case studies of commercially-driven phenotypic prediction where regulation is sparse and market incentives are high. What can these case studies tell us about what responsible entrepreneurship in genomic prediction looks like, and how can we apply it in our own work?
Come discuss these issues with a cross-disciplinary group. All are welcome and lunch is included!
The Berkeley Ethics and Regulation Group for Innovative Technologies (BERGIT) is an ideas exchange and a meeting ground for collaborations across disciplines to integrate ethics, regulation, and policy with science. BERGIT is hosted by the IGI and led by an interdisciplinary team with expertise in ethics, law, and molecular biology. Participants come from institutions around the Bay Area and beyond.
Please join our email list to hear about future meetings.
We strive to make our events accessible and inclusive. The Innovative Genomics Institute Building is ADA accessible, and has a lactation room that visitors can use. For disability accommodation information and requests and/or access to the lactation room, please contact Kristy Nordahl at email@example.com or 510-664-7110.